FBIO
Fortress Biotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$91.63M
P/E Ratio
0.85
EPS
$3.23
Beta
1.16
52W High
$4.53
52W Low
$1.70
50-Day MA
$2.48
200-Day MA
$3.00
Dividend Yield
—
Profit Margin
10.80%
Forward P/E
1.16
PEG Ratio
-0.10
About Fortress Biotech Inc
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $63.26M |
| Gross Profit (TTM) | $30.44M |
| EBITDA | $-65.56M |
| Operating Margin | -29.80% |
| Return on Equity | -108.70% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $2.27 |
| Book Value | $1.59 |
| Price-to-Book | 0.57 |
| Price-to-Sales (TTM) | 1.45 |
| EV/Revenue | 1.127 |
| EV/EBITDA | -0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.30% |
| Shares Outstanding | $33.22M |
| Float | $22.38M |
| % Insiders | 22.79% |
| % Institutions | 18.16% |
Historical Volatility
HV 10-Day
80.68%
HV 20-Day
64.03%
HV 30-Day
61.55%
HV 60-Day
60.63%
HV Rank
52.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($11.00 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026